Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1) Audited ....
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company has scheduled a Board meeting for May 28, 2026 to consider approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The meeting agenda also includes variation in objects of the company's IPO and conduct of a postal ballot. Notably, the board will also consider the appointment of a Chief Executive Officer. The trading window remains closed from April 1, 2026 until 48 hours after the announcement of the audited financial results.
The appointment of a new CEO is a significant governance development that could impact investor sentiment positively or negatively depending on the nominee's profile. The IPO object variation may indicate a change in capital deployment strategy.